Behavioral and neurobiological effects of deep brain stimulation in a mouse model of high anxiety-and depression-like behavior

Neuropsychopharmacology

Volumn 38, Issue 7, 2013, Pages 1234-1244

  Schmuckermair, Claudia ^a   Gaburro, Stefano ^a   Sah, Anupam ^a   Landgraf, Rainer ^b   Sartori, Simone B ^a   Singewald, Nicolas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

antidepressant; c Fos; deep brain stimulation; neurogenesis; nucleus accumbens; treatment resistant depression

Indexed keywords

CITALOPRAM; DESIPRAMINE; FLUOXETINE; PAROXETINE; PROTEIN C FOS; REBOXETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BEHAVIOR; BRAIN DEPTH STIMULATION; CINGULATE GYRUS; CONTROLLED STUDY; DENTATE GYRUS; DEPRESSION; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; IMMOBILIZATION; IMMUNOHISTOCHEMISTRY; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROBIOLOGY; NONHUMAN; NUCLEUS ACCUMBENS; ORBITAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS; TREATMENT RESPONSE;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; DEEP BRAIN STIMULATION; DENTATE GYRUS; DEPRESSION; HIPPOCAMPUS; MALE; MICE; MICE, INBRED STRAINS; NEUROGENESIS; NUCLEUS ACCUMBENS;

EID: 84878525795     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2013.21     Document Type: Article

References (91)

1. Al-Harbi KS (2012). Treatment-resistant depression: therapeutic trends, challenges, and future directions. Patient Pref Adher 6: 369-388.
2. Barr LC, Heninger GR, Goodman W, Charney DS, Price LH (1997). Effects of fluoxetine administration on mood response to tryptophan depletion in healthy subjects. Biol Psychiatry 41: 949-954.
3. Benabid AL, Benazzous A, Pollak P (2002). Mechanisms of deep brain stimulation. Mov Disor 17(Suppl 3): S73-S74.
4. Berton O, Nestler EJ (2006). New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7: 137-151.
5. Bewernick BH, Hurlemann R, Matusch A, Kayser S, Grubert C, Hadrysiewicz B et al (2010). Nucleus accumbens deep brain stimulation decreases ratings of depression and anxiety in treatment-resistant depression. Biol Psychiatry 67: 110-116.
6. Bewernick BH, Kayser S, Sturm V, Schlaepfer TE (2012). Longterm effects of nucleus accumbens deep brain stimulation in treatment-resistant depression: evidence for sustained efficacy. Neuropsychopharmacology 37: 1975-1985.
7. Borsini F (2012). Models for depression in drug screening and preclinical studies: future directions. World J Pharmacol 1: 21-29.
8. Carboni L, Becchi S, Piubelli C, Mallei A, Giambelli R, Razzoli M et al (2010). Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuro-Psycharm Biol Psych 34: 1037-1048.
9. Coenen VA, Schlaepfer TE, Maedler B, Panksepp J (2011). Crossspecies affective functions of the medial forebrain bundleimplications for the treatment of affective pain and depression in humans. Neurosci Biobehav Rev 35: 1971-1981.
10. Couillard-Despres S, Wuertinger C, Kandasamy M, Caioni M, Stadler K, Aigner R et al (2009). Ageing abolishes the effects of fluoxetine on neurogenesis. Mol Psychiatry 14: 856-864.
11. Cryan JF, Mombereau C (2004). In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326-357.
12. Cryan JF, Mombereau C, Vassout A (2005). The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice. Neurosci Biobehav Rev 29: 571-625.
13. Denys D, Mantione M, Figee M, van den Munckhof P, Koerselman F, Westenberg H et al (2010). Deep brain stimulation of the nucleus accumbens for treatment-refractory obsessive-compulsive disorder. Arch Gen Psychiatry 67: 1061-1068.
14. Disner SG, Beevers CG, Haigh EA, Beck AT (2011). Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci 12: 467-477.
15. Dostrovsky JO, Lozano AM (2002). Mechanisms of deep brain stimulation. Movem Disord 17(Suppl 3): S63-S68.
16. Encinas JM, Hamani C, Lozano AM, Enikolopov G (2011). Neurogenic hippocampal targets of deep brain stimulation. J Comp Neurol 519: 6-20.
17. Encinas JM, Vaahtokari A, Enikolopov G (2006). Fluoxetine targets early progenitor cells in the adult brain. Proc Natl Acad Sci USA 103: 8233-8238.
18. Falowski SM, Sharan A, Reyes BA, Sikkema C, Szot P, Van Bockstaele EJ (2011). An evaluation of neuroplasticity and behavior after deep brain stimulation of the nucleus accumbens in an animal model of depression. Neurosurgery 69: 1281-1290.
19. Fisher R, Salanova V, Witt T, Worth R, Henry T, Gross R et al (2010). Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy. Epilepsia 51: 899-908.
20. Floresco SB, Todd CL, Grace AA (2001). Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci 21: 4915-4922.
21. Fostick L, Silberman A, Beckman M, Spivak B, Amital D (2010). The economic impact of depression: resistance or severity? Eur Neuropsychopharmacol 20: 671-675.
22. Franklin KBJ, Paxinos G (2007). The Mouse Brain in Stereotaxic Coordinates. 3rd edn Elsevier Academic Press: New York, US.A.
23. Friedman A, Lax E, Abraham L, Tischler H, Yadid G (2012). Abnormality of VTA local field potential in an animal model of depression was restored by patterned DBS treatment. Eur Neuropsychopharmacol 22: 64-71.
24. Gaburro S, Stiedl O, Giusti P, Sartori SB, Landgraf R, Singewald N (2011). A mouse model of high trait anxiety shows reduced heart rate variability that can be reversed by anxiolytic drug treatment. Int J Neuropsychopharmacol 14: 1341-1355.
25. Gelfin Y, Gorfine M, Lerer B (1998). Effect of clinical doses of fluoxetine on psychological variables in healthy volunteers. Am J Psychiatry 155: 290-292.
26. Gorwood P (2008). Neurobiological mechanisms of anhedonia. Dialog Clin Neurosci 10: 291-299.
27. Gutman DA, Holtzheimer PE, Behrens TE, Johansen-Berg H, Mayberg HS (2009). A tractography analysis of two deep brain stimulation white matter targets for depression. Biol Psychiatry 65: 276-282.
28. Haber SN, Knutson B (2010). The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacol 35: 4-26.
29. Hamani C, Diwan M, Macedo CE, Brandao ML, Shumake J, Gonzalez-Lima F et al (2010). Antidepressant-like effects of medial prefrontal cortex deep brain stimulation in rats. Biol Psychiatry 67: 117-124.
30. Hamani C, Machado DC, Hipolide DC, Dubiela FP, Suchecki D, Macedo CE et al (2012). Deep brain stimulation reverses anhedonic-like behavior in a chronic model of depression: role of serotonin and brain derived neurotrophic factor. Biol Psychiatry 71: 30-35.
31. Heldmann M, Berding G, Voges J, Bogerts B, Galazky I, Muller U et al (2012). Deep brain stimulation of nucleus accumbens region in alcoholism affects reward processing. PLoS One 7: e36572.
32. Hiemke C, Hartter S (2000). Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85: 11-28.
33. Hoyer C, Kranaster L, Sartorius A, Hellweg R, Gass P (2012). Longterm course of brain-derived neurotrophic factor serum levels in a patient treated with deep brain stimulation of the lateral habenula. Neuropsychobiology 65: 147-152.
34. Keck ME, Sartori SB, Welt T, Muller MB, Ohl F, Holsboer F et al (2005). Differences in serotonergic neurotransmission between rats displaying high or low anxiety/depression-like behaviour: effects of chronic paroxetine treatment. J Neurochem 92: 1170-1179.
35. Kelley AE, Stinus L (1984). The distribution of the projection from the parataenial nucleus of the thalamus to the nucleus accumbens in the rat: an autoradiographic study. Exp Brain Res 54: 499-512.
36. Kempton MJ, Salvador Z, Munafo MR, Geddes JR, Simmons A, Frangou S et al (2011). Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 68: 675-690.
37. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 593-602.
38. Kingwell K (2010). Depression: In pursuit of happiness. Nat Rev Neurosci 11: 786.
39. Koenig AM, Thase ME (2009). First-line pharmacotherapies for depression-what is the best choice? Pol Arch Med Wewn 119: 478-486.
40. Kringelbach ML, Green AL, Owen SL, Schweder PM, Aziz TZ (2010). Sing the mind electric-principles of deep brain stimulation. Eur J Neurosci 32: 1070-1079.
41. Krishnan V, Nestler EJ (2008). The molecular neurobiology of depression. Nature 455: 894-902.
42. Kroeze Y, Zhou H, Homberg JR (2012). The genetics of selective serotonin reuptake inhibitors. Pharmacol Ther 136: 375-400.
43. Kromer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L et al (2005). Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci 25: 4375-4384.
44. Landgraf R, Kessler MS, Bunck M, Murgatroyd C, Spengler D, Zimbelmann M et al (2007). Candidate genes of anxiety-related behavior in HAB/LAB rats and mice: focus on vasopressin and glyoxalase-I. Neurosci Biobehav Rev 31: 89-102.
45. Lee BT, Seong Whi C, Hyung Soo K, Lee BC, Choi IG, Lyoo IK et al (2007). The neural substrates of affective processing toward positive and negative affective pictures in patients with major depressive disorder. Prog Neuro-Psycharm Biol Psych 31: 1487-1492.
46. Lim LW, Tan SK, Groenewegen HJ, Temel Y (2011). Electrical brain stimulation in depression: which target(s)? Biol Psychiatry 69: e5-e6 author reply e7-8.
47. Lozano AM, Giacobbe P, Hamani C, Rizvi SJ, Kennedy SH, Kolivakis TT et al (2012). A multicenter pilot study of subcallosal cingulate area deep brain stimulation for treatment-resistant depression. J Neurosurg 116: 315-322.
48. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, Craddock RC, Kennedy SH (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biol Psychiatry 64: 461-467.
49. Luciano M, Del Vecchio V, Giacco D, De Rosa C, Malangone C, Fiorillo A (2012). A 'family affair'? The impact of family psychoeducational interventions on depression. Expert Rev Neurother 12: 83-91.
50. Luigjes J, de Kwaasteniet BP, de Koning PP, Oudijn MS, van den Munckhof P, Schuurman PR et al (2012). Surgery for psychiatric disorders. World Neurosurg, doi:10.1016/j.wneu.2012.03.009 (in press).
51. Malone DA Jr, Dougherty DD, Rezai AR, Carpenter LL, Friehs GM, Eskandar EN et al (2009). Deep brain stimulation of the ventral capsule/ventral striatum for treatment-resistant depression. Biol Psychiatry 65: 267-275.
52. Mayberg HS, Lozano AM, Voon V, McNeely HE, Seminowicz D, Hamani C et al (2005). Deep brain stimulation for treatmentresistant depression. Neuron 45: 651-660.
53. McCracken CB, Grace AA (2007). High-frequency deep brain stimulation of the nucleus accumbens region suppresses neuronal activity and selectively modulates afferent drive in rat orbitofrontal cortex in vivo. J Neurosci 27: 12601-12610.
54. McCracken CB, Grace AA (2009). Nucleus accumbens deep brain stimulation produces region-specific alterations in local field potential oscillations and evoked responses in vivo. J Neurosci 29: 5354-5363.
55. McIntyre CC, Grill WM (1999). Excitation of central nervous system neurons by nonuniform electric fields. Biophys J 76: 878-888.
56. McIntyre CC, Savasta M, Walter BL, Vitek JL (2004). How does deep brain stimulation work? Present understanding and future questions. J Clin Neurophysiol 21: 40-50.
57. Milne AM, MacQueen GM, Hall GB (2012). Abnormal hippocampal activation in patients with extensive history of major depression: an fMRI study. J Psychiatry Neurosci 37: 28-36.
58. Moreines JL, McClintock SM, Holtzheimer PE (2011). Neuropsychologic effects of neuromodulation techniques for treatmentresistant depression: a review. Brain Stimul 4: 17-27.
59. Muigg P, Hoelzl U, Palfrader K, Neumann I, Wigger A, Landgraf R et al (2007). Altered brain activation pattern associated with drug-induced attenuation of enhanced depression-like behavior in rats bred for high anxiety. Biol Psychiatry 61: 782-796.
60. Muigg P, Scheiber S, Salchner P, Bunck M, Landgraf R, Singewald N (2009). Differential stress-induced neuronal activation patterns in mouse lines selectively bred for high, normal or low anxiety. PLoS One 4: e5346.
61. Nauta WJ, Domesick VB (1984). Afferent and efferent relationships of the basal ganglia. Ciba Found Symp 107: 3-29.
62. Nowak LG, Bullier J (1998a). Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements. Exp Brain Res 118: 477-488.
63. Nowak LG, Bullier J (1998b). Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Exp Brain Res 118: 489-500.
64. Parkinson JA, Olmstead MC, Burns LH, Robbins TW, Everitt BJ (1999). Dissociation in effects of lesions of the nucleus accumbens core and shell on appetitive pavlovian approach behavior and the potentiation of conditioned reinforcement and locomotor activity by D-amphetamine. J Neurosci 19: 2401-2411.
65. Rodriguez-Romaguera J, Do Monte FH, Quirk GJ (2012). Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear. Proc Natl Acad Sci USA 109: 8764-8769.
66. Sah A, Schmuckermair C, Sartori SB, Gaburro S, Kandasamy M, Irschick R et al (2012). Anxiety-rather than depression-like behavior is associated with adult neurogenesis in a female mouse model of higher trait anxiety-and comorbid depression-like behavior. Transl Psychiatry 2: e171.
67. Salome N, Salchner P, Viltart O, Sequeira H, Wigger A, Landgraf R et al (2004). Neurobiological correlates of high (HAB) versus low anxiety-related behavior (LAB): differential Fos expression in HAB and LAB rats. Biol Psychiatry 55: 715-723.
68. Samuels BA, Hen R (2011). Neurogenesis and affective disorders. Eur J Neurosci 33: 1152-1159.
69. Sartori SB, Hauschild M, Bunck M, Gaburro S, Landgraf R, Singewald N (2011a). Enhanced fear expression in a psychopathological mouse model of trait anxiety: pharmacological interventions. PLoS One 6: e16849.
70. Sartori SB, Landgraf R, Singewald N (2011b). The clinical implications of mouse models of enhanced anxiety. Fut Neurol 6: 531-571.
71. Sartori SB, Whittle N, Hetzenauer A, Singewald N (2012). Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment. Neuropharmacology 62: 304-312.
72. Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, Ende G (2007). Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. NeuroReport 18: 1469-1473.
73. Schermer M (2011). Ethical issues in deep brain stimulation. Front Integr Neurosci 5: 17.
74. Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N et al (2008). Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 33: 368-377.
75. Singewald N (2007). Altered brain activity processing in highanxiety rodents revealed by challenge paradigms and functional mapping. Neurosci Biobehav Rev 31: 18-40.
76. Stone SS, Teixeira CM, Devito LM, Zaslavsky K, Josselyn SA, Lozano AM et al (2011). Stimulation of entorhinal cortex promotes adult neurogenesis and facilitates spatial memory. J Neurosci 31: 13469-13484.
77. Tan SK, Hartung H, Visser-Vandewalle V, Steinbusch HW, Temel Y, Sharp T (2012). A combined in vivo neurochemical and electrophysiological analysis of the effect of high-frequency stimulation of the subthalamic nucleus on 5-HT transmission. Exp Neurol 233: 145-153.
78. Toda H, Hamani C, Fawcett AP, Hutchison WD, Lozano AM (2008). The regulation of adult rodent hippocampal neurogenesis by deep brain stimulation. J Neurosurg 108: 132-138.
79. Tremblay LK, Naranjo CA, Graham SJ, Herrmann N, Mayberg HS, Hevenor S et al (2005). Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62: 1228-1236.
80. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STARD: implications for clinical practice. Am J Psychiatry 163: 28-40.
81. van der Plasse G, Schrama R, van Seters SP, Vanderschuren LJ, Westenberg HG (2012). Deep brain stimulation reveals a dissociation of consummatory and motivated behaviour in the medial and lateral nucleus accumbens shell of the rat. PLoS One 7: e33455.
82. van Kuyck K, Gabriels L, Cosyns P, Arckens L, Sturm V, Rasmussen S et al (2007). Behavioural and physiological effects of electrical stimulation in the nucleus accumbens: a review. Acta Neurochir Suppl 97(Part 2): 375-391.
83. Vieta E, Colom F (2011). Therapeutic options in treatmentresistant depression. Ann Med 43: 512-530.
84. Vitek JL (2002). Mechanisms of deep brain stimulation: excitation or inhibition. Movem Disord 17(Suppl 3): S69-S72.
85. Wang Y, Yang F, Liu YF, Gao F, Jiang W (2011). Acetylsalicylic acid as an augmentation agent in fluoxetine treatment resistant depressive rats. Neurosci Lett 499: 74-79.
86. Whittle N, Li L, Chen WQ, Yang JW, Sartori SB, Lubec G et al (2011). Changes in brain protein expression are linked to magnesium restriction-induced depression-like behavior. Amino Acids 40: 1231-1248.
87. Winter C, Vollmayr B, Djodari-Irani A, Klein J, Sartorius A (2011). Pharmacological inhibition of the lateral habenula improves depressive-like behavior in an animal model of treatment resistant depression. Behav Brain Res 216: 463-465.
88. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al (2011). The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21: 655-679.
89. Yeragani VK, Pohl R, Mallavarapu M, Balon R (2003). Approximate entropy of symptoms of mood: an effective technique to quantify regularity of mood. Bipolar Disord 5: 279-286.
90. Zangenehpour S, Chaudhuri A (2002). Differential induction and decay curves of c-fos and zif268 revealed through dual activity maps. Brain Res Mol Brain Res 109: 221-225.
91. Zhao C, Deng W, Gage FH (2008). Mechanisms and functional implications of adult neurogenesis. Cell 132: 645-660.